Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06609005 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
A Phase 1 study of Advanced Metastatic Castration Resistant Prostate Cancer, sponsored by Shenzhen Ionova Life Sciences Co..
- Recruiting
- Registry status
- Phase 1
- Development phase
- 84
- Enrollment target
- 17
- Study locations
NCT06609005 is a Phase 1 study of Advanced Metastatic Castration Resistant Prostate Cancer that is actively recruiting participants, run by Shenzhen Ionova Life Sciences Co.. The registered enrollment target is 84 participants. The trial reports 17 study locations across 14 states.
The verdict
NCT06609005, a Phase 1 study of Advanced Metastatic Castration Resistant Prostate Cancer, is actively recruiting participants, sponsored by Shenzhen Ionova Life Sciences Co..
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 84 participants
- Enrollment target
- 17
- Study locations
Study Summary
This is a Phase 1 and Phase 2 study to evaluate the safety and antitumor activity of INV-9956 in adult patients with advanced metastatic Castration Resistant Prostate Cancer.
Conditions Studied
Interventions
- DRUG INV-9956
Study Locations (17)
California
- Hoag Family Cancer Institute - Newport Beach
- UC Irvine Medical Center - Orange
Texas
- Next Oncology - Houston - Houston
- UT Health - San Antonio
Zhejiang
- The First Affiliated Hospital, School of Medicine, Zhejiang University - Hangzhou
- Zhejiang Provincial People's Hospital - Hangzhou
Arizona
- Honor Health - Scottsdale
Virginia
- NEXT Oncology - Fairfax
Washington
- Summit Cancer Centers - Spokane
Fujian
- The First Affiliated Hospital of Fujian Medical University - Fuzhou
He'Nan
- He'nan Cancer Hospital - Zhengzhou
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2025-01-23 |
| Est. Completion | 2028-01-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06609005
The ClinicalTrials.gov registry entry for NCT06609005 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shenzhen Ionova Life Sciences Co., which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Advanced Metastatic Castration Resistant Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which INV-9956 is the first listed.
NCT06609005 reports 17 study locations spanning 14 distinct geographic areas - top geographies include California, Texas, Zhejiang.
Frequently Asked Questions
What is clinical trial NCT06609005 about?
NCT06609005 is a clinical study titled "A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer". This is a Phase 1 and Phase 2 study to evaluate the safety and antitumor activity of INV-9956 in adult patients with advanced metastatic Castration Resistant Prostate Cancer.
What is the current status of trial NCT06609005?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 84 participants. The study started on 2025-01-23. Estimated completion is 2028-01-17.
What conditions does trial NCT06609005 study?
This clinical trial studies the following conditions: Advanced Metastatic Castration Resistant Prostate Cancer.
What interventions are being tested in trial NCT06609005?
The interventions under investigation include: INV-9956 (DRUG).
Who is sponsoring clinical trial NCT06609005?
This trial is sponsored by Shenzhen Ionova Life Sciences Co., which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06609005 being conducted?
This trial has 17 study locations across Arizona, California, Texas, Virginia, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Metastatic Castration Resistant Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.